Moreover, some authors have observed a neuroprotective role of IL-6 since it might induce myelin repair in inactive demyelinated lesions from MS patients [7] or even that the exogenous administration of IL-6 or its production may reduce the clinical signs of EAE [25,26,27]. The gene discussed is IL6; the disease is myeloid sarcoma.